J P Mohr Selected Research

J P Mohr Research Topics

27	Stroke (Strokes) 01/2018 - 01/2002
18	Ischemic Stroke 10/2016 - 03/2000
11	Heart Failure 01/2018 - 01/2008
5	Hemorrhage 09/2015 - 11/2001
4	Arteriovenous Malformations (Arteriovenous Malformation) 10/2017 - 02/2000
4	Patent Foramen Ovale 07/2009 - 06/2002
3	Cerebral Hemorrhage 01/2016 - 01/2013
3	Embolic Stroke 09/2004 - 08/2002
2	Transient Ischemic Attack 01/2016 - 03/2003
2	Atrial Fibrillation 03/2013 - 08/2002
2	Carotid Stenosis (Carotid Artery Stenosis) 07/2010 - 01/2000
2	Aphasia (Dysphasia) 03/2003 - 01/2002
2	Paresis (Hemiparesis) 01/2002 - 01/2000
1	Thromboembolism 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hypertension (High Blood Pressure) 09/2015
1	Systolic Heart Failure 01/2014
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2012
1	Carotid Artery Diseases 02/2012
1	Myocardial Infarction 07/2010
1	Left Ventricular Dysfunction 01/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2006
1	Aneurysm (Aneurysms) 06/2002
1	Brain Ischemia (Cerebral Ischemia) 01/2002
1	Perceptual Disorders (Hemispatial Neglect) 01/2002
1	Embolism (Embolus) 11/2001
1	Pathologic Constriction (Stenosis) 01/2000
1	Horner Syndrome (Horner's Syndrome) 01/2000
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 01/2000
1	Pain (Aches) 01/2000

21	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 11/2001
21	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 11/2001
4	AnticoagulantsIBA 01/2018 - 01/2003
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 11/2001
3	Antiphospholipid AntibodiesIBA 07/2009 - 08/2002
2	Anticardiolipin AntibodiesIBA 07/2009 - 02/2004
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 07/2009 - 02/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2006 - 01/2002
2	Midazolam (Versed)FDA LinkGeneric 03/2003 - 01/2002
1	Angiotensin Receptor AntagonistsIBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	NitrogenIBA 01/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2013
1	pro-brain natriuretic peptide (1-76)IBA 03/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2008
1	Carbon DioxideIBA 03/2006
1	Thrombin FDA Link 09/2004
1	Hemostatics (Antihemorrhagics)IBA 09/2004
1	Prothrombin (Factor II)IBA 09/2004
1	AntibodiesIBA 02/2004
1	Pharmaceutical PreparationsIBA 03/2003
1	Heparinoids (Heparinoid)IBA 08/2002
1	Heparin (Liquaemin)FDA LinkGeneric 08/2002
1	gamma-Aminobutyric Acid (GABA)IBA 01/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2002
1	A-factor (Streptomyces)IBA 01/2000
1	Retinaldehyde (Retinal)IBA 01/2000
1	Anesthetics (Anesthetic Agents)IBA 01/2000

15	Therapeutics 10/2017 - 01/2002
3	Endarterectomy (Thromboendarterectomy) 12/2012 - 01/2000
2	Carotid Endarterectomy 12/2012 - 07/2010
2	Thrombolytic Therapy 06/2002 - 03/2000
1	Thrombectomy 05/2003
1	Treatment Delay 06/2002
1	Catheters 01/2002
1	Radiotherapy 02/2000
1	Injections 01/2000
1	Therapeutic Embolization 01/2000